{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:19:15Z","timestamp":1775060355273,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Kurdistan University of Medical Sciences, Sanandaj, Iran","award":["IR.MUK.REC.1397.352"],"award-info":[{"award-number":["IR.MUK.REC.1397.352"]}]},{"name":"Project of Ministry of Education, Science and Technology of the Republic of Serbia","award":["III45005"],"award-info":[{"award-number":["III45005"]}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Mycologie M\u00e9dicale"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.mycmed.2020.100935","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T11:36:08Z","timestamp":1580384168000},"page":"100935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis"],"prefix":"10.1016","volume":"30","author":[{"given":"Z.","family":"Salehi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Fatahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Taran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Izadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Badali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.J.","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Rezaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Daie Ghazvini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Aala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Barac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Khodavaisy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2020.100935_bib0005","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.mycmed.2015.02.046","article-title":"Updating the epidemiology of dermatophyte infections in Palestine with special reference to concomitant dermatophytosis","volume":"25","author":"Ali-Shtayeh","year":"2015","journal-title":"J Mycol Med"},{"key":"10.1016\/j.mycmed.2020.100935_bib0010","first-page":"151","article-title":"Ultrastructural alterations in the epidermis of patients with Tinea pedis","volume":"2","author":"Canberk","year":"2011","journal-title":"Balk Med J"},{"key":"10.1016\/j.mycmed.2020.100935_bib0015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.29252\/cmm.3.1.20","article-title":"Epidemiological status of dermatophytosis in Guilan, north of Iran","volume":"3","author":"Fallahi","year":"2017","journal-title":"Curr Med mycol"},{"key":"10.1016\/j.mycmed.2020.100935_bib0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/13693786.2012.686124","article-title":"Molecular epidemiology of dermatophytosis in Tehran, Iran, a clinical and microbial survey","volume":"51","author":"Rezaei-Matehkolaei","year":"2013","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2020.100935_bib0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11046-005-7458-5","article-title":"A study of dermatophytosis in South West of Iran (Ahwaz)","volume":"160","author":"Mahmoudabadi","year":"2005","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2020.100935_bib0030","first-page":"312","article-title":"Prevalence of superficial fungal infections among sports-active individuals: results from the Achilles survey, a review of the literature","volume":"15","author":"Caputo","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.mycmed.2020.100935_bib0035","doi-asserted-by":"crossref","first-page":"e02423","DOI":"10.1128\/AAC.02423-17","article-title":"In vitro antifungal activity of novel triazole efinaconazole and five comparators against dermatophyte isolates","volume":"62","author":"Rezaei-Matehkolaei","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2020.100935_bib0040","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1128\/AAC.02056-12","article-title":"Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis","volume":"57","author":"Siu","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2020.100935_bib0045","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/0897190016660487","article-title":"Tavaborole, Efinaconazole, and Luliconazole: three new Antimycotic agents for the treatment of Dermatophytic fungi","volume":"30","author":"Saunders","year":"2017","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.mycmed.2020.100935_bib0050","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.mycmed.2017.11.004","article-title":"Luliconazole, a new antifungal against Candida species isolated from different sources","volume":"28","author":"Taghipour","year":"2018","journal-title":"J Mycol Med"},{"key":"10.1016\/j.mycmed.2020.100935_bib0055","article-title":"Potent Activity of Luliconazole, Lanoconazole and Eight Comparators against Molecularly Characterized Fusarium species","volume":"632","author":"Abastabar","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2020.100935_bib0060","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A2","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.mycmed.2020.100935_bib0065","first-page":"98","article-title":"Onychomycosis in North-East of Iran","volume":"6","author":"Afshar","year":"2014","journal-title":"Iran J Microbiol"},{"key":"10.1016\/j.mycmed.2020.100935_bib0070","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.mycmed.2016.06.007","article-title":"Epidemiological trends of dermatophytosis in Tehran, Iran: a five-year retrospective study","volume":"26","author":"S. Zamani","year":"2016","journal-title":"J Mycol Med"},{"key":"10.1016\/j.mycmed.2020.100935_bib0075","doi-asserted-by":"crossref","first-page":"e1002564","DOI":"10.1371\/journal.ppat.1002564","article-title":"A foot in the door for dermatophyte research","volume":"8","author":"Achterman","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mycmed.2020.100935_bib0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11046-012-9571-6","article-title":"In vitro antifungal activity of micafungin and caspofungin against dermatophytes isolated from China","volume":"175","author":"Bao Y-q","year":"2013","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2020.100935_bib0085","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.1128\/AAC.01193-16","article-title":"Potent activities of novel imidazoles lanoconazole and luliconazole against a collection of azole-resistant and -susceptible Aspergillus fumigatus strains","volume":"60","author":"Abastabar","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2020.100935_bib0090","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00635-17","article-title":"In vitro activity of luliconazole, lanoconazole, and efinaconazole compared with five antifungal drugs against melanized fungi and relatives","volume":"61","author":"Shokoohi","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2020.100935_bib0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10156-006-0440-4","article-title":"In vitro antifungal activity of luliconazole against clinical isolates from patients with dermatomycoses","volume":"12","author":"Koga","year":"2006","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.mycmed.2020.100935_bib0100","doi-asserted-by":"crossref","first-page":"e00115","DOI":"10.1128\/AAC.00115-17","article-title":"Terbinafine resistance of Trichophyton clinical isolates caused by specific point mutations in the squalene epoxidase gene","volume":"61","author":"Yamada","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2020.100935_bib0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.7547\/14-109","article-title":"Azole resistance in dermatophytes: prevalence and mechanism of action","volume":"106","author":"Ghannoum","year":"2016","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.mycmed.2020.100935_bib0110","first-page":"e17149","article-title":"In vitro additive effect on griseofulvin and terbinafine combinations against multidrug-resistant dermatophytes","volume":"54","author":"Lana","year":"2018","journal-title":"Braz J Pharm"},{"key":"10.1016\/j.mycmed.2020.100935_bib0115","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s10096-018-3317-4","article-title":"Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates","volume":"37","author":"Salehi","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"}],"updated-by":[{"DOI":"10.1016\/j.mycmed.2020.101006","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000}}],"container-title":["Journal de Mycologie M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523319302926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523319302926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:20:17Z","timestamp":1761110417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523319302926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1156523319302926"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2020.100935","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis","name":"articletitle","label":"Article Title"},{"value":"Journal de Mycologie M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2020.100935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100935"}}